| HS Code | 887463 |
| Brand Name | ZEMIDAPA Tab. |
| Generic Name | Dapagliflozin |
| Strength | 10 mg |
| Dosage Form | Tablet |
| Route Of Administration | Oral |
| Therapeutic Class | SGLT2 inhibitor |
| Indication | Type 2 Diabetes Mellitus |
| Manufacturer | SK Chemicals |
| Storage Conditions | Store below 30°C, away from moisture and light |
| Prescription Status | Prescription only |
As an accredited ZEMIDAPA Tab. factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | ZEMIDAPA Tab. packaging features a white blister pack containing 10 tablets, boxed in blue-accented cardboard with bold printed labeling. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for ZEMIDAPA Tab.: Typically accommodates up to 350,000–400,000 tablets, securely packed for international shipping. |
| Shipping | **Shipping Description for ZEMIDAPA Tab.:** ZEMIDAPA Tab. should be shipped in its original, sealed packaging, protected from moisture, heat, and direct sunlight. It must be transported under ambient conditions unless otherwise specified. Ensure compliance with local regulations for pharmaceutical products, and include proper documentation and labelling during shipping. Handle with care to prevent damage. |
| Storage | **ZEMIDAPA Tab.** should be stored in a well-closed container at a temperature not exceeding 30°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging until use. Store in a dry place, away from children and incompatible substances. Ensure proper labeling and adhere to local regulatory requirements for pharmaceutical storage. |
| Shelf Life | The shelf life of ZEMIDAPA Tab. is typically 24 months when stored in a cool, dry place away from sunlight. |
ZEMIDAPA Tab. is produced for precise industrial needs where its chemical properties enhance process performance and output quality. Below, we outline practical downstream scenarios based on verified market usage, operational standards, and manufacturing steps adopted by commercial producers.
Major APIs production lines use ZEMIDAPA Tab. as a precursor or intermediate for dapagliflozin-related compounds. Manufacturers introduce this material during the active pharmaceutical ingredient synthesis stage to maintain controlled impurity profiles and batch reproducibility. Strict documentation follows ICH Q7 guidelines, and every batch integrates with downstream tableting or encapsulation, forming finished metformin/dapagliflozin co-formulations or monotherapy tablets. As a manufacturer, we ensure the raw material supports consistent particle size, critical for process validation during granulation and compression.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Midstream specialty chemical producers use ZEMIDAPA Tab. to synthesize advanced glycoside intermediates for flavor and fragrance or further pharmaceutical chemical pathways. The material is dosed at controlled rates to ensure specific functional group protection or activation, directly impacting chirality and end-use reactivity. Our QC team tailors shipments to fulfill documentation requested by REACH and C&L inventory compliance at customer facilities, enabling full auditable traceability from batch to batch.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Large-scale contract manufacturers employ ZEMIDAPA Tab. during batch blending for oral solid dosage products. Operators introduce the raw material at the direct blending stage to achieve precise API loadings, while in-line NIR spectroscopy monitors content uniformity. The preparation supports both single-ingredient and fixed-dose combinations, and the entire workflow remains traceable according to FDA DMF filing and serial number-based traceability systems. We supply tailored technical documentation to fulfill customer-specific audit requirements and batch release specifications.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Chemical reagent suppliers incorporate ZEMIDAPA Tab. when producing batch-controlled laboratory research compounds and analytical standards. The precise starting material enhances consistency across investigative use, with every lot meeting documentation for analytical-grade purity. Our QA release records align with ISO 17034 and global laboratory reagent import documentation, aiding direct academic or industrial R&D consumption.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive ZEMIDAPA Tab. prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618018036652 or mail to sales6@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618018036652
Email: sales6@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Long hours running tablet presses in our own plant have taught us that not every granular ingredient behaves the same. Our process lines run tight schedules, and whenever a grade fails to meet target hardness or creates excess dust, troubleshooting chews through time and raw material. We designed ZEMIDAPA Tab. to sidestep those headaches. By stripping down common causes of sticking and poor flow, this product helps operators keep lines moving, especially in humid environments where lesser grades become unpredictable.
Years ago, we managed constant interruptions during high-output campaigns, always around coated particles clumping together or binder ratios that refused to stay consistent. Instead of accepting these as “industry challenges,” our team went to the lab and rebuilt our dicalcium phosphate anhydrous tablet grade from the processing up. We tweaked crystal structure and surface finish again and again to balance compressibility and dispersion during blending. We put hundreds of kilo runs through high-speed rotary presses, not just bench-top batches.
ZEMIDAPA Tab. sets a clear standard in loss-on-drying moisture levels, with tightly controlled targets to resist caking after long-term storage. Average particle size rests in the mid-micron range, based on die-filling trials, not someone’s idea of what “should work.” We keep sieve cuts consistent, so changes in flow don’t trip up your production line during feeder refills. Every shipment moves only after we confirm compressibility indexes and bulk density numbers match those we post, not some idealized chart.
Real-world comments shaped this tablet excipient more than marketing pitches. In the early pilot runs, shifts complained when scaling up routines led to inconsistent weight variations. Tablets pressed with standard DCPA grades looked brittle on visual inspection, and more than once, cracked during transfer. Our formulation delivers tablets with a smooth edge and even dimensions. Machine techs now report that fewer routine cleanings and dust emissions translate directly to less downtime and better air quality.
Older filling systems tend to clog or bridge after several hours with generic DCPA products, especially in press rooms where temperature and humidity waver by shift. We installed ZEMIDAPA Tab. across lines using high-speed and single-punch presses. Over several months of continuous production, dosage uniformity stayed within acceptance ranges, and tablets held together through automated packaging. The resistance to chipping held up through rough loading and final drum transport. This reliability gives our team more confidence for longer batch cycles.
During pilot runs, we noticed most filler grades forced us to overuse lubricants. That led to lamination and surface slickness—tablets that didn’t punch out cleanly or required adjustments on the fly. By controlling the morphology of each particle, ZEMIDAPA Tab. maintains low ejection forces, even at minimal lubricant concentrations. This saves cost and keeps formulas lean, a real plus when running sensitive actives or those troubled by magnesium stearate incompatibilities. Changeovers take less time, since less residue sticks to tooling or gets caught in punch dies.
Every minute a technician spends chasing flow inconsistencies cuts into operational hours. ZEMIDAPA Tab. made a noticeable difference for our rotary press teams. Operators found that die fill levels stayed stable well beyond a single production campaign. Less bridging and rat-holing in hoppers meant batch changeovers pushed up productivity by several percent over an average quarter. Packaging line managers saw dust levels drop on catch trays, leaving more product in tablets rather than air or equipment surfaces.
Running a chemical plant, we never just looked at output. Our own operators asked for better dust containment. Each test run with ZEMIDAPA Tab. saw a measurable dip in airborne particles, which means less exposure and safer working conditions. Factory cleaned up faster after each campaign. Fewer airborne fines made maintenance easier, helped us stay within workplace exposure limits, and gave us peace of mind during audits.
Older blends absorbed atmospheric moisture, gumming up machinery and forcing line stops. After rainy spells, storage rooms once saw pallets fuse into solid blocks from caked DCPA. With the ZEMIDAPA Tab. model, changes in temperature or humidity barely register. Regular stability checks through warm, damp months showed no change in tablet breakdown times or compressive strength. Teams running extended shifts preferred ZEMIDAPA Tab. because it kept granulate texture consistent, fed through blenders the same way at 6AM as at 6PM.
We understand cost pressures better than anyone. Many blending houses look for ways to reduce the number of excipients in a mix. Our product succeeds in direct compression routes, cutting down process steps and additive lists. On our own lines, we have used ZEMIDAPA Tab. as the exclusive filler for direct compression batches, eliminating the need for pre-granulation in many of our processes. Formulation specialists who tested tablets after aging cycles found active ingredient content intact and tablet friability near the low end, even after months on the shelf.
Large plants know that every false alarm raises costs—one test out-of-range and dozens of pallets may need isolation for retesting or even scrapping. Since introducing ZEMIDAPA Tab. into our lines, complaints about off-spec tablets almost vanished. Audit trails show lots matched label claims across months of regular sampling. Forward integration into electronic batch records proved smoother since analysis results landed well inside agreed-upon boundaries.
A few years back, our research pushed for incremental gains rather than wild innovation. We worked batch after batch tweaking bonding agent blends, pressing force settings, and drying times, and each change fed directly into ZEMIDAPA Tab.’s finished spec. This iterative design, based on repeated operator input, led to a product easy to press, store, and blend. Over time, process engineers trimmed cycle times, maintenance crews handled less time-consuming cleanup, and QA teams found fewer variant tablets landing in sample trays.
Not every excipient fits every recipe. In our experience, ZEMIDAPA Tab. matches well with vitamins and minerals prone to reactivity, especially when working compounds liable to discolor or break down at high tablet press forces. Its surface profile minimizes hot spots that often trigger undesirable reactions. Several formulations using sensitive active ingredients, such as ascorbic acid or certain trace elements, returned higher assay recoveries when switching from generic grades to our improved model.
One of the most difficult places to keep process efficiency high is in multi-product facilities where lines see frequent changeovers and varied batch sizes. We tested our product through both short and long runs, and its predictable compressibility kept process parameters steady after only minor calibration. Compression force readings stayed in a narrow range, so fewer trial tablets got discarded. Clean-in-Place protocols cleared bulk residue with little water and minimal scrubbing. This led to lower water use and less wasted time during verification steps.
Bulk DCPA products from generic suppliers usually ship with a wide spread in moisture level, particle size, and flowability. We found these inconsistencies forced process techs to tweak every new lot or even blend incompatible batches together, wasting time and raw material. Our approach with ZEMIDAPA Tab. standardized those variables, so presses achieve peak output without the constant minor adjustments that slow campaigns. This meant less overtime for line staff and fewer recalibrations.
Our full traceability system tracks ZEMIDAPA Tab. from raw mineral feed to final drum. Each lot receives documentation showing it meets both local and global standards for tablet manufacturing excipients. Regular audits ensure no cross-contamination with other batches. Having run regulatory submission trials ourselves, we know a stable, predictable filler removes one friction point in the often time-consuming path to finished product approval. No regulatory authority wants to see unexplained lot-to-lot variation in excipient composition.
Working directly with pharma and nutritional producers on four continents, feedback shaped every revision of ZEMIDAPA Tab. Production teams installing the product sent technicians to observe batch runs in our plant facilities. Onsite, our staff answered direct questions about performance. These relationships drove us to tighten internal tolerances and publish open, verifiable test data. Customers running batches in Southeast Asia during monsoon season and in northern climates with dry air both reported stable performance from opening to campaign close.
Unlike generic lines, we reinvested in our production to further refine ZEMIDAPA Tab. Each year brings new automation features in our blending and drying lines. Consistent upgrades in particle sizing, humidity control, and filtration mean every new drum matches the expectations set by the old one. Stability studies compare every lot to previous years’ output, not just to a static minimum spec. Quality lab runs stress tests under overstated industrial conditions rather than relaxed benchmarks.
Operators detailed mundane but critical wins: quicker hopper reloads, less jammed sieves, and easier cleaning under equipment. Long-time press supervisors compared multi-week downtime data and found hours saved in both planned and unplanned interventions. Techs working midnight shifts reported the same handling and feeding reliability as those on fresh, early-morning production starts. Small details, learned over years, add up to larger impacts on efficiency and employee satisfaction.
Scrap rates dropped by measurable amounts over multiple continuous production periods following switchovers to ZEMIDAPA Tab. Plant records showed fewer out-of-weight tablets, and breakdown tests in finished packs registered more stable disintegration times even after shipping across long distances. Less rework meant more “right the first time” product and increased confidence at every step of production.
Our plant has purchased, trialed, and shelved several commodity DCPA grades that failed side-by-side testing against our own batches. We saw firsthand how unnoticed inconsistencies in raw feed, particle shape, or drying conditions can trigger process failures. Our thorough process control system closes these gaps well before product ever reaches press operators. This, not luck, leads to steady tablet characteristics over continuous production months rather than just a handful of test runs.
Our lots link into traceability platforms, so any deviation triggers reviews before release. By welding these quality processes into daily routines, we manage rapid recalls in the unlikely event of a specification failure. This proactive stance keeps our warehouses free of uncertain stockpiles, freeing up working capital and storage for active lines. Customers receive true-to-batch certificates matching physical shipments rather than generic paperwork.
Our experience shows reliable excipients make life easier for distribution, packaging, and even last-mile logistics. Drums loaded with stable, consistently flowing ZEMIDAPA Tab. handle better on packaging conveyors. Quality teams down invoice chains reported fewer reports of caked or clumped product on arrival. By holding moisture and flow targets to tight bands, we minimize temperature and transit-related surprises.
We learned that laboratory data sets could never tell the full story. Our operators frequently suggested changes—no matter how minor—based on daily routines, and we followed their lead. Each adjustment cascades through process design, from line layout to maintenance scheduling. ZEMIDAPA Tab. reflects this plant-based approach, not a catalogue item tweaked only for bench-top numbers. Every process improvement cycle, from lab to QA to logistics to pressroom, links back to how this excipient performs in the real world.
Our journey to improve tableting outcomes did not follow a standard playbook. Years of blended industrial and technician experience brought hundreds of small optimizations, each solving a nagging problem remembered from a late-night shift or a surprise audit. By integrating this lived experience into every lot of ZEMIDAPA Tab., we help real tableting teams—like our own—work with greater confidence and fewer surprises. This product emerged from genuine process challenges and continues to evolve based on new plant experiences, not theoretical use cases alone.